• Chrono-medical & Chrono-psychological assessment
This is an assessment of biorhythms and the autonomic nervous system through heart rate variability analysis, that will give you a detailed understanding of your health risk and health potential, performance under duress, capacity to recuperate, quality of sleep and physiological adaptability.
• Sleep assessments
such as overnight oximetry, multiple sleep latency test or polysomnogram conducted at the Sleep Centre of the London Bridge Hospital.
• RCGG Test: Oncocount
This test detects the presence of circulating tumour cells and measures their concentration in the blood. As these cells could lead to the recurrence of a cancer, this test may be useful to detect relapse early, and can assist as a follow-up tool.
The CellSearch Circulating Tumour Cell (CTC) test is a simple blood test that helps oncologists in assessing the prognosis of patients with metastatic breast, colorectal, or prostate cancer.
The CellSearch test is the only FDA-approved test for CTC assessment.
The test also gives indications about the viability of anti-cancer chemotherapy drugs and the patient's ability to metabolize them. It may identify cancer cell mutations that can cause resistance to therapies.
It is also a possibility to test natural substances, which may be used to support conventional oncology treatments.
• NutrEval and One Test (Genova Diagnostics)
NutrEval and One Tests identify key nutritional deficiencies. The NutrEval FMV evaluates overall nutritional status to determine personalized supplementation needs for antioxidants, B-vitamins, minerals, essential fatty acids, amino acids, digestive support, and other select nutrients.
• Immunological test for chronic infections